This sale was conducted to cover tax withholding obligations related to the release of Restricted Stock Units on January 21, 2025. According to InvestingPro analysis, which offers comprehensive ...
Mark Jeffrey DeLong, Chief Business & Strategy Officer at Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), recently sold 1,396 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback